EVOLVE: Difference between revisions

Jump to navigation Jump to search
30 bytes added ,  26 August 2015
no edit summary
No edit summary
No edit summary
Line 151: Line 151:
''Censoring of data at six months after study-drug discontinuation was performed''
''Censoring of data at six months after study-drug discontinuation was performed''


; Primary Composite Endpoint
; Time to Death or First Nonfatal Cardiovascular Event
: HR=0.85 (CI 0.76-0.95; P=0.003)
: HR=0.85 (CI 0.76-0.95; P=0.003)


; Mortality
; Time to Death
: HR=0.83 (CI 0.73-0.96; P=0.009)<!-- remove when cleared by an editor -->
: HR=0.83 (CI 0.73-0.96; P=0.009)<!-- remove when cleared by an editor -->


495

edits

Navigation menu